The Intravenous Galactose Test as Indicator of the Extent of Fibrosis in Patients with Cirrhosis of the Liver
- 1 January 1969
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 4 (5) , 453-456
- https://doi.org/10.3109/00365526909180632
Abstract
The values of the intravenous galactose test in control subjects and in patients with cirrhosis of the liver were compared with some laboratory findings and the extent of fibrosis in liver biopsies. In 10 control subjects the average T/2 value of the galactose test was 13 minutes (range 9′ to 15′ 30″). In 10 patients with light fibrosis, the values were not significantly different from controls. On the other hand, in 10 patients with severe fibrosis, the fibrotic tissue occupying more than 30 per cent of the liver lobules, a highly significantly prolonged T/2 of the galactose test was found (23 minutes and 23 seconds).Keywords
This publication has 7 references indexed in Scilit:
- A methodological study of the enzymatic determination of galactose in human whole blood, plasma and erythrocytes with galactose oxidaseClinica Chimica Acta; International Journal of Clinical Chemistry, 1967
- A galactose-oxidase method for the determination of galactose in blood plasmaClinica Chimica Acta; International Journal of Clinical Chemistry, 1962
- The “half-life” concept in the determination of the functional capacity of the liverClinica Chimica Acta; International Journal of Clinical Chemistry, 1959
- Kinetics of Galactose Elimination.Acta Physiologica Scandinavica, 1954
- A new galactose test for differentiation of obstructive from parenchymatous jaundiceDigestive Diseases and Sciences, 1941
- AN INTRAVENOUS GALACTOSE-TOLERANCE TESTThe Lancet, 1940
- Intravenous galactose liver function testAmerican Journal of Digestive Diseases and Nutrition, 1936